(ALNY) Alnylam - Performance 76.7% in 12m
Compare ALNY with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
64.13%
#8 in Group
Rel. Strength
94.49%
#422 in Universe
Total Return 12m
76.66%
#12 in Group
Total Return 5y
137.94%
#18 in Group
P/E -
(unknown) Percentile in Group
P/E Forward 1.00K
100th Percentile in Group
PEG -0.49
18th Percentile in Group
FCF Yield -0.13%
78th Percentile in Group
12m Total Return: ALNY (76.7%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: ALNY vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ALNY
Total Return (including Dividends) | ALNY | XBI | S&P 500 |
---|---|---|---|
1 Month | 9.57% | -5.85% | -3.01% |
3 Months | 14.22% | -11.95% | -3.15% |
12 Months | 76.66% | -11.00% | 10.19% |
5 Years | 137.94% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | ALNY | XBI | S&P 500 |
1 Month | 73.4% | -59.8% | -5.5% |
3 Months | 16.2% | -70.5% | -58.4% |
12 Months | 50.2% | -6.9% | 84.1% |
5 Years | 68.0% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #27 | 16.4% | 13.0% |
3 Month | #22 | 29.7% | 17.9% |
12 Month | #12 | 98.5% | 60.3% |
5 Years | #19 | 136% | 3.80% |
FAQs
Does ALNY Alnylam outperforms the market?
Yes,
over the last 12 months ALNY made 76.66%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months ALNY made 14.22%, while XBI made -11.95%.
Over the last 3 months ALNY made 14.22%, while XBI made -11.95%.
Performance Comparison ALNY vs Indeces and Sectors
ALNY vs. Indices ALNY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -0.16% | 12.6% | -1.61% | 66.5% |
US NASDAQ 100 | QQQ | 0.82% | 13.6% | -0.84% | 68.1% |
US Dow Jones Industrial 30 | DIA | -0.36% | 11.7% | -2.53% | 67.2% |
German DAX 40 | DAX | 1.14% | 13.0% | -18.4% | 55.0% |
Shanghai Shenzhen CSI 300 | CSI 300 | 0.13% | 9.34% | 13.6% | 67.5% |
Hongkong Hang Seng | HSI | -2.13% | 6.80% | 7.61% | 59.3% |
India NIFTY 50 | INDA | -1.19% | 1.70% | 8.74% | 76.0% |
Brasil Bovespa | EWZ | -0.27% | 1.28% | 6.39% | 88.4% |
ALNY vs. Sectors ALNY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 1.38% | 13.4% | -9.72% | 57.5% |
Consumer Discretionary | XLY | -0.92% | 13.4% | -4.97% | 62.6% |
Consumer Staples | XLP | -2.95% | 11.4% | -2.45% | 65.6% |
Energy | XLE | -1.25% | 1.55% | -7.19% | 75.9% |
Financial | XLF | -0.64% | 12.3% | -13.8% | 54.4% |
Health Care | XLV | -0.58% | 12.7% | 3.09% | 75.0% |
Industrial | XLI | -0.47% | 10.3% | -0.90% | 68.1% |
Materials | XLB | -1.26% | 9.06% | 6.50% | 80.6% |
Real Estate | XLRE | -2.20% | 12.3% | 1.51% | 63.3% |
Technology | XLK | 0.97% | 13.6% | 3.51% | 74.7% |
Utilities | XLU | -3.45% | 8.75% | -0.73% | 51.4% |
Aerospace & Defense | XAR | 0.44% | 8.29% | -5.53% | 55.7% |
Biotech | XBI | 4.40% | 15.4% | 16.1% | 87.7% |
Homebuilder | XHB | -0.66% | 9.42% | 17.8% | 84.4% |
Retail | XRT | -2.46% | 10.1% | 2.47% | 81.5% |